Publications: Lopresti, Adrian

Journal Article

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2020) Association between micronutrients and heart rate variability: A review of human studies. Advances in Nutrition, 11 (3). pp. 559-575.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Smith, S.J., Metse, A.P.ORCID: 0000-0002-8641-1024 and Drummond, P.D. (2020) Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Sleep Medicine, 16 (6). pp. 937-947.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Smith, S.J. and Drummond, P.D. (2020) Herbal treatments for migraine: A systematic review of randomised‐controlled studies. Phytotherapy Research . Early View.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Smith, S.J., Metse, A.P.ORCID: 0000-0002-8641-1024, Foster, T. and Drummond, P.D. (2020) The feasibility and efficacy of a brief integrative treatment for adults with depression and/or anxiety: A randomized controlled trial. Journal of Evidence-Based Integrative Medicine, 25 .

Marx, W., Lane, M., Rocks, T., Ruusunen, A., Loughman, A., Lopresti, A.ORCID: 0000-0002-6409-7839, Marshall, S., Berk, M., Jacka, F. and Dean, O.M. (2019) Effect of saffron supplementation on symptoms of depression and anxiety: A systematic review and meta-analysis. Nutrition Reviews, 77 (8). pp. 557-571.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Smith, S.J., Hood, S.D. and Drummond, P.D. (2019) Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology . In Press.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2019) It is time to investigate integrative approaches to enhance treatment outcomes for depression? Medical Hypotheses, 126 . pp. 82-94.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2019) The effects of psychological and environmental stress on micronutrient concentrations in the body: A review of the evidence. Advances in Nutrition, 11 (1). pp. 103-112.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Smith, S.J., Malvi, H. and Kodgule, R. (2019) An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract. Medicine, 98 (37).

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Drummond, P.D. and Smith, S.J. (2019) A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. American Journal of Men's Health, 13 (2).

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2018) The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects? Advances in Nutrition, 9 (1). pp. 41-50.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Drummond, P.D., Inarejos-García, A.M. and Prodanov, M. (2018) affron ® , a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: A randomised, double-blind, placebo-controlled study. Journal of Affective Disorders, 232 . pp. 349-357.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Gupta, H. and Smither, S.J. (2018) A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study. BMC Complementary and Alternative Medicine, 18 (1). Article number 98.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2017) Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Australian & New Zealand Journal of Psychiatry, 51 (6). pp. 565-582.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2017) Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. Journal of Psychopharmacology, 31 (3). pp. 287-302.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 and Drummond, P.D. (2017) Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. Journal of Affective Disorders, 207 . pp. 188-196.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2017) Salvia (Sage): A review of its potential cognitive-enhancing and protective effects. Drugs in R&D, 17 (1). pp. 53-64.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Maes, M., Meddens, M.J.M., Maker, G.L.ORCID: 0000-0003-1666-9377, Arnoldussen, E. and Drummond, P.D. (2015) Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. European Neuropsychopharmacology, 25 (1). pp. 38-50.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 and Jacka, F.N. (2015) Diet and Bipolar Disorder: A Review of Its Relationship and Potential Therapeutic Mechanisms of Action. The Journal of Alternative and Complementary Medicine, 21 (12). pp. 733-739.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2015) Oxidative and nitrosative stress in ADHD: Possible causes and the potential of antioxidant-targeted therapies. ADHD Attention Deficit and Hyperactivity Disorders, 7 (4). pp. 237-247.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2015) A review of nutrient treatments for paediatric depression. Journal of Affective Disorders, 181 (August). pp. 24-32.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Maes, M., Maker, G.L.ORCID: 0000-0003-1666-9377, Hood, S.D. and Drummond, P.D. (2014) Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167 . pp. 368-375.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 and Drummond, P.D. (2014) Saffron (Crocus sativus) for depression: A systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology: Clinical and Experimental, 29 (6). pp. 517-527.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Maker, G.L.ORCID: 0000-0003-1666-9377, Hood, S.D. and Drummond, P.D. (2014) A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 48 . pp. 102-111.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 and Drummond, P.D. (2013) Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 45 . pp. 92-99.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Hood, S.D. and Drummond, P.D. (2013) A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise. Journal of Affective Disorders, 148 (1). pp. 12-27.

Lopresti, A.L.ORCID: 0000-0002-6409-7839, Hood, S.D. and Drummond, P.D. (2012) Multiple antidepressant potential modes of action of curcumin: A review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. Journal of Psychopharmacology, 26 (12). pp. 1512-1524.

Book Chapter

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2019) Mitochondrial dysfunction and oxidative stress: Relevance to the pathophysiology and treatment of depression. In: Quevedo, J., Carvalho, A.F. and Carlos, A., (eds.) Neurobiology of Depression. Academic Press, pp. 159-168.

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2015) Contribution of Diet and Exercise in the Pathogenesis of Major Depression. In: Farooqui, T. and Farooqui, A.A., (eds.) Diet and Exercise in Cognitive Function and Neurological Diseases. Wiley Blackwell, Hoboken, New Jersey, pp. 93-104.

Thesis

Lopresti, A.L.ORCID: 0000-0002-6409-7839 (2014) Dysregulated biological pathways in major depression: An examination of the antidepressant effects of curcumin. PhD thesis, Murdoch University.